Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 3 studies | 24% ± 7% |
Insufficient scRNA-seq data for expression of TNFRSF10A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 719.18 | 578 / 578 | 99% | 18.23 | 1143 / 1155 |
esophagus | 98% | 471.95 | 1421 / 1445 | 98% | 21.38 | 180 / 183 |
breast | 100% | 675.87 | 459 / 459 | 96% | 12.80 | 1073 / 1118 |
intestine | 95% | 406.50 | 920 / 966 | 100% | 21.72 | 525 / 527 |
stomach | 95% | 229.68 | 341 / 359 | 99% | 19.47 | 283 / 286 |
thymus | 100% | 392.68 | 651 / 653 | 92% | 10.79 | 559 / 605 |
uterus | 100% | 328.45 | 170 / 170 | 87% | 14.75 | 400 / 459 |
prostate | 100% | 370.47 | 245 / 245 | 87% | 6.72 | 437 / 502 |
bladder | 90% | 328.43 | 19 / 21 | 94% | 15.38 | 476 / 504 |
pancreas | 88% | 156.74 | 287 / 328 | 95% | 19.32 | 169 / 178 |
kidney | 93% | 342.92 | 83 / 89 | 87% | 11.17 | 788 / 901 |
liver | 95% | 282.96 | 215 / 226 | 70% | 5.27 | 285 / 406 |
skin | 100% | 507.65 | 1805 / 1809 | 46% | 4.73 | 219 / 472 |
ovary | 44% | 64.11 | 80 / 180 | 83% | 5.82 | 357 / 430 |
adrenal gland | 97% | 258.09 | 250 / 258 | 27% | 2.15 | 63 / 230 |
adipose | 100% | 658.01 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 14.51 | 29 / 29 |
spleen | 100% | 631.80 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.85 | 1 / 1 |
tonsil | 0% | 0 | 0 / 0 | 98% | 21.37 | 44 / 45 |
peripheral blood | 93% | 295.76 | 863 / 929 | 0% | 0 | 0 / 0 |
heart | 90% | 169.07 | 773 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 85% | 195.99 | 1130 / 1335 | 0% | 0 | 0 / 0 |
muscle | 60% | 77.44 | 485 / 803 | 0% | 0 | 0 / 0 |
brain | 35% | 50.44 | 924 / 2642 | 10% | 0.49 | 68 / 705 |
eye | 0% | 0 | 0 / 0 | 4% | 0.17 | 3 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0097191 | Biological process | extrinsic apoptotic signaling pathway |
GO_0071260 | Biological process | cellular response to mechanical stimulus |
GO_0007165 | Biological process | signal transduction |
GO_0008625 | Biological process | extrinsic apoptotic signaling pathway via death domain receptors |
GO_0036462 | Biological process | TRAIL-activated apoptotic signaling pathway |
GO_0006915 | Biological process | apoptotic process |
GO_0007250 | Biological process | activation of NF-kappaB-inducing kinase activity |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0005886 | Cellular component | plasma membrane |
GO_0045121 | Cellular component | membrane raft |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0009986 | Cellular component | cell surface |
GO_0005829 | Cellular component | cytosol |
GO_0045569 | Molecular function | TRAIL binding |
GO_0038023 | Molecular function | signaling receptor activity |
GO_0005035 | Molecular function | death receptor activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0002020 | Molecular function | protease binding |
GO_0005515 | Molecular function | protein binding |
Gene name | TNFRSF10A |
Protein name | TNF receptor superfamily member 10a Alternative protein TNFRSF10A Tumor necrosis factor receptor superfamily member 10a Tumor necrosis factor receptor superfamily member 10A (Death receptor 4) (TNF-related apoptosis-inducing ligand receptor 1) (TRAIL receptor 1) (TRAIL-R1) (CD antigen CD261) TNF receptor superfamily member 10a (Tumor necrosis factor receptor superfamily member 10a variant 2) |
Synonyms | TRAILR1 APO2 DR4 |
Description | FUNCTION: Receptor for the cytotoxic ligand TNFSF10/TRAIL . The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis . Promotes the activation of NF-kappa-B . . FUNCTION: Receptor for the cytotoxic ligand TNFSF10/TRAIL. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. . |
Accessions | O00220 ENST00000524158.5 F8U8C0 ENST00000613472.1 ENST00000221132.8 C1K3N4 L8EA63 E5RFH1 |